Figures & data
Table 1 Criteria for Clinical Evaluation of Allergic Ocular Findings
Figure 1 Percentage of IFN-γ-producing CD4+ T cells in PBMC. The results are expressed in percent as mean ± SEM (*P < 0.05).
![Figure 1 Percentage of IFN-γ-producing CD4+ T cells in PBMC. The results are expressed in percent as mean ± SEM (*P < 0.05).](/cms/asset/158e95e7-8f1a-48f8-8b7a-4616267f9ec6/djaa_a_12151627_f0001_c.jpg)
Figure 2 Percentage of IL-4-producing CD4+ T cells in PBMC. The results are expressed in percent as mean ± SEM (***P < 0.001).
![Figure 2 Percentage of IL-4-producing CD4+ T cells in PBMC. The results are expressed in percent as mean ± SEM (***P < 0.001).](/cms/asset/589e9864-5f85-4df0-bf7c-85f3a59e7607/djaa_a_12151627_f0002_c.jpg)
Figure 3 Percentage of IFN-γ-producing CD4+ T cells in conjunctiva. The results are expressed in percent as mean ± SEM (*P < 0.05; **P < 0.01; ***P < 0.001).
![Figure 3 Percentage of IFN-γ-producing CD4+ T cells in conjunctiva. The results are expressed in percent as mean ± SEM (*P < 0.05; **P < 0.01; ***P < 0.001).](/cms/asset/6c4edfcd-bd94-4de3-8626-0662f590dfb4/djaa_a_12151627_f0003_c.jpg)
Figure 4 Percentage of IL-4-producing CD4+ T cells in conjunctiva. The results are expressed in percent as mean ± SEM (**P < 0.01; ***P < 0.001; ****P<0.0001).
![Figure 4 Percentage of IL-4-producing CD4+ T cells in conjunctiva. The results are expressed in percent as mean ± SEM (**P < 0.01; ***P < 0.001; ****P<0.0001).](/cms/asset/0f99b85d-4804-43aa-b4bb-4dbfd1cbe4c7/djaa_a_12151627_f0004_c.jpg)
Table 2 Correlation Between Percentage of IFN-γ- or IL-4-Producing CD4+ T Cells in PBMC or Conjunctiva and Clinical Score in Patients with SBS